Big Tech Capex Fuels AI Discussions, Hims & Hers Faces FDA Action, and Trump's Equity Stakes Raise Concerns

Major tech companies are significantly increasing capital expenditures, driving discussions around AI infrastructure and potential beneficiaries beyond
$NVDA.
Telehealth provider
$HIMS faced regulatory intervention from the FDA regarding its compounded semaglutide pill.
Concerns were raised about the Trump administration's equity stakes in US companies, including
$MP Materials and
$INTC.
The valuation of
$RDDT and its CEO's stock sales were debated on r/stocks.

Big Tech Capex and AI Investment Drive Market Discussions

Discussions highlighted a significant acceleration in capital expenditures by major technology companies, with projections indicating a 44% year-over-year increase to approximately $610 billion in 2026. This surge in spending, particularly from

$META,

$AMZN,

$GOOG, and

$MSFT, sparked interest in identifying investment opportunities beyond

$NVDA that could benefit from this wave of investment in Artificial Intelligence infrastructure.

$AMZN's commitment of $200 billion to AI initiatives, despite an initial 9% stock drop, led to discussions on r/stocks regarding whether the market's negative reaction was an overreaction or a legitimate concern about return on investment. Some drew parallels to the early days of AWS, which also faced skepticism about its ROI.

AMZN

The increasing demand for AI chips, particularly from

$NVDA, was noted as influencing the strategies of major tech companies, pushing them towards advancing their own AI chip efforts. This trend was compared to IBM in the 1960s, where the emergence of computers led to vertical integration.

Hims & Hers Under Regulatory Spotlight

Telehealth provider

$HIMS announced it would cease offering access to its compounded semaglutide pill following intervention from the U.S. Food and Drug Administration. This development, reported on r/wallstreetbets, sparked discussions about the potential impact on the company's revenue and market position.

Separately, a significant r/wallstreetbets post detailed a $550,000 YOLO bet on

$HIMS stock, with the author anticipating a positive impact from a Super Bowl advertisement.

Trump Administration's Equity Stakes Raise Risks

A discussion on r/stocks highlighted concerns regarding the Trump administration's equity stakes in U.S. companies. The unprecedented scale of these holdings, which include companies like

$MP Materials,

$INTC,

$X, and

$REMX, were seen as posing risks such as conflicts of interest and potential capital misallocation.

Reddit's Valuation and Leadership Scrutiny

The stock performance of

$RDDT became a point of contention, with discussions on r/stocks questioning the CEO's stock selling and its potential impact on shareholder confidence. A comparative analysis also emerged, suggesting that

$RDDT's run-rate P/E ratio had caught up to

$GOOG and

$GOOGL's Q4 run-rate P/E ratio.

Broader Market Themes

Other notable discussions included the projection of global semiconductor sales reaching $1 trillion in 2026, indicating significant year-over-year growth and bullish sentiment for companies like

$MU,

$AAPL, and

$TSM. The potential merger between

$NFLX and

$WBD was also analyzed for its regulatory implications. Additionally,

$BB garnered attention on r/pennystocks as it quietly rebuilds as an enterprise software company.

Top Mentioned Tickers

Live market context for tickers referenced in this article.

#	Symbol	Rank	Comments	Users	Price	Vol	24h	Mrkt Cap.
1	AMZN	-	-	-	-	-	-	-
2	MSFT	-	-	-	-	-	-	-
3	NVDA	-	-	-	-	-	-	-
4	META	-	-	-	-	-	-	-
5	PLTR	-	-	-	-	-	-	-

Updated live

Subscribe to Tendie.bot for more market recaps.